D. Boral Capital Interview with Rob Etherington, President & CEO of Clene
Dec 10, 2025
Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2026 Clene Nanomedicine, Inc. - All rights reserved | PRIVACY POLICY | COOKIE POLICY | TERMS OF USE